A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants
Background A global shift to bivalent mRNA vaccines is ongoing to counterbalance the
diminishing effectiveness of the original monovalent vaccines due to the evolution of SARS …
diminishing effectiveness of the original monovalent vaccines due to the evolution of SARS …
[HTML][HTML] Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and …
FCM Kirsebom, K Harman, RJ Lunt… - The Lancet Regional …, 2023 - thelancet.com
Background Since the first emergence of Omicron BA. 1 in England in November 2021,
numerous sub-lineages have evolved. In September 2022, BA. 5 dominated. The …
numerous sub-lineages have evolved. In September 2022, BA. 5 dominated. The …
[HTML][HTML] Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
M Cheng, R Li, Z Weng, G Song - Frontiers in Medicine, 2024 - frontiersin.org
Objective The rapid development of COVID-19 bivalent vaccines (BVs) has encompassed
both the original virus strains and the variant strain. However, the effectiveness of BVs is …
both the original virus strains and the variant strain. However, the effectiveness of BVs is …
[HTML][HTML] Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged≥ 60 years during the Omicron XBB lineage …
L Antunes, C Mazagatos, I Martínez-Baz… - …, 2024 - eurosurveillance.org
We conducted a multicentre hospital-based test-negative case–control study to measure the
effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS …
effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS …
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three …
F Riefolo, B Castillo-Cano, M Martín-Pérez, D Messina… - Vaccine, 2023 - Elsevier
Abstract Using 4 data-sources (Spain, Italy, United Kingdom) data and a 1: 1 matched cohort
study, we aimed to estimate vaccine effectiveness (VE) in preventing SARS-CoV-2 infections …
study, we aimed to estimate vaccine effectiveness (VE) in preventing SARS-CoV-2 infections …
Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community …
Introduction We assessed protection from coronavirus disease 2019 (COVID-19) vaccines
and/or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
and/or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
Effectiveness of the adjuvanted Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA. 4-5) bivalent vaccines against hospitalisation …
Abstract Background In England, the Joint Committee for Vaccination and Immunisation
recommended a spring 2023 booster programme for all adults aged 75 years and older and …
recommended a spring 2023 booster programme for all adults aged 75 years and older and …
[HTML][HTML] Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
The initial two-dose vaccine series and subsequent booster vaccine doses have been
effective in modulating SARS-CoV-2 disease severity and death but do not completely …
effective in modulating SARS-CoV-2 disease severity and death but do not completely …
[HTML][HTML] Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023
B Liu, S Stepien, K Sharma, K Macartney - Eurosurveillance, 2023 - eurosurveillance.org
We followed 4,081,257 Australian adults aged≥ 65 years between November 2022 and
May 2023 for COVID-19-specific mortality, when recombinant SARS-CoV-2 Omicron …
May 2023 for COVID-19-specific mortality, when recombinant SARS-CoV-2 Omicron …
[HTML][HTML] Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged≥ 65 years: results from a VEBIS network, Europe, October 2021 to July …
M Fontán-Vela, E Kissling, N Nicolay… - …, 2024 - eurosurveillance.org
To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of
the first, second and third COVID-19 booster (vs complete primary vaccination), we …
the first, second and third COVID-19 booster (vs complete primary vaccination), we …